Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d92933b9403f6dd88ae55cf818c5045e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-242 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-242 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-67 |
filingDate |
2015-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbaf2d4c106a473cc860aa1a9d57f427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fab28b5a6d89b9f5e52e79f574447b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_026bfb2464e88adf0448cf3fb66a48dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7a17c22d998a7d1373793486be8ad93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1954bcd861dfd019457adbfc1537a813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b042a1743bdbd573de2e7deb78dde7ae |
publicationDate |
2018-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9919049-B2 |
titleOfInvention |
Combinations of a photosensitizer with a hydrogen sulfide donor, thioredoxin inhibitor or nitroxide for use in photodynamic therapy |
abstract |
Compounds for use The invention relates to a combination comprising (i) a compound A comprising a mitochondrial targeting group linked to a group capable of releasing hydrogen sulfide or a pharmaceutically acceptable salt thereof or a prodrug thereof, an inhibitor of the thioredoxin antioxidant system or pharmaceutically acceptable salt thereof or a prodrug thereof, and/or a nitroxide or a pharmaceutically acceptable salt thereof or a prodrug thereof; and (ii) a photosensitizer or photosensitizer precursor; for use in photodynamic therapy. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10149907-B2 |
priorityDate |
2014-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |